SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056242
Filing Date
2021-11-10
Accepted
2021-11-10 16:40:30
Documents
12
Period of Report
2021-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20211108.htm   iXBRL 8-K 34299
  Complete submission text file 0001564590-21-056242.txt   162121

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hsto-20211108.xsd EX-101.SCH 5697
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20211108_lab.xml EX-101.LAB 19326
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20211108_pre.xml EX-101.PRE 11495
5 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20211108_htm.xml XML 3547
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 211397349
SIC: 2834 Pharmaceutical Preparations